Cycle threshold values at which a specific number of dogs out of 11 dogs was able to detect SARS-CoV-2 in samples from Merida, Yucatán, México. by Víctor M. Vidal-Martínez (18707335)

Subjects:

Results of a dog’s detections after exposure to sweat samples from positive and negative people to SARS-CoV-2, together with the Ct values of the RT-qPCR test of each person partic... by Víctor M. Vidal-Martínez (18707335)

Subjects:

Boxplot comparing Ct values for HD in flies and clothes. by Philippe Ndzomo (17706039)

Gaussian model fitted of the number of dogs detections of SARS-CoV-2, depending on the cycle threshold (Ct) values of RT-qPCR tests for SARS-CoV-2. by Víctor M. Vidal-Martínez (18707335)

Subjects:

The spike-in of synthetic hsa-lest-7a-5p miRNA decreases the Ct Values of extracted small RNA samples. by Marc Van Der Hofstadt (1423027)

CT Values of reference materials. by Guosong Jing (20840261)

Sensitivity and specificity of 11 dogs trained to detect SARS -CoV-2 from the sweat of positive and negative people from Mérida, Yucatán compared with the reference test (RT-qPCR).... by Víctor M. Vidal-Martínez (18707335)

Subjects:

Details of the 11 fully trained dogs exposed to sweat samples of SARS-CoV-2 positive and negative humans. by Víctor M. Vidal-Martínez (18707335)

Subjects:

Madrasin decreases transcription of protein-coding genes. by Michael Tellier (8284752)

Madrasin decreases transcription of protein-coding genes. by Michael Tellier (8284752)

CT outcome of HPDL-MIAIHD technique with other methods. by Naif Almakayeel (16846021)

Subjects:

CT outcome of HPDL-MIAIHD technique with recent methods. by Naif Almakayeel (16846021)

Subjects:

a Non-reducing SDS-PAGE of test samples and by Vanessa Radtke (1674097)

Yeast encapsulation of a PSI can decrease the phototoxicity against microorganisms and increase the phototoxicity against mosquito larvae. by Cole J. Meier (17377064)

Table 1_Previous treatment decreases efficacy of pralsetinib in RET fusion-positive non-small-cell lung cancer.doc by Lei Wang (6656)

“…Background<p>Pralsetinib is a selective RET inhibitor. The ARROW trial revealed that RET fusion-positive non-small-cell lung cancer (NSCLC) can benefit from pralsetinib with tolerable adverse events (AEs). …”

(A) The incidence of OME in the VA group compared to the non-VA group. (B) The rate of tympanostomy tube insertion in the VA group and non-VA group. by Miki Kashiwagi (21439684)

Additional file 8 of Decreased complement 4 and interleukin-10 as biomarkers in aqueous humour for non-exudative age-related macular degeneration: a case control study by Juliane Schikora (20871169)

Additional file 2 of Decreased complement 4 and interleukin-10 as biomarkers in aqueous humour for non-exudative age-related macular degeneration: a case control study by Juliane Schikora (20871169)

Additional file 5 of Decreased complement 4 and interleukin-10 as biomarkers in aqueous humour for non-exudative age-related macular degeneration: a case control study by Juliane Schikora (20871169)

Additional file 1 of Decreased complement 4 and interleukin-10 as biomarkers in aqueous humour for non-exudative age-related macular degeneration: a case control study by Juliane Schikora (20871169)